About Us

Accugentix LLC was officially founded in 2018 by Alainah Hacker, Founder & CEO. Alainah has a Bachelor’s of Science in Biology and a minor in Economics from Florida Gulf Coast University (FGCU). She graduated Cum Laude with Honors in 2018 with a full academic scholarship. In 2013 Alainah enrolled at FGCU through an Early Admissions program and dedicated over 110+ hours of community service for STEM & Education events, Lee County Mosquito Control, etc. Alongside community service hours, Alainah has completed over 500 hours of tutoring K-12 & college level students. Throughout college, Alainah worked in the medical device industry part-time. Before graduating from FGCU, Alainah founded Accugentix LLC in January 2018 after spending many months developing ideas and filing multiple patent applications for dosing technologies. After graduating from college, Alainah had gained more experience in a medical device laboratory and also became a certified Special Needs Teacher for K-12 and certified Middle School math teacher. While working other jobs, Alainah focused on prototyping an Accugentix product and developing innovative ideas in the health industry.

The ideas for Accugentix began after Alainah attended a meeting at FGCU in Spring of 2017 with a local representative speaking on the issues of medical marijuana regulations in the state of Florida. Florida had just legalized medical marijuana in the state in 2016, and there were many questions on how the state would be regulating the use of a formerly illegal drug for medical patients. One of the main issues in the industry was dosing. Government and doctors could not regulate how much a medical marijuana patient was consuming. This is when Alainah brainstormed ideas and came to the conclusion that many industries within holistic & alternative medicine are unregulated and there is a lack of guidance for patients. The goal for Accugentix was the fill the gaps across many unregulated health industries. The concepts behind Accugentix are hidden the name: accurate treatments specific to a patient’s genetics. An example of this are micro-dosing tools, which allow patients to identify the most accurate dosing for their specific needs. Currently, the only device functionality Accugentix is developing is micro-dosing.